Targretin
Brand for: Bexarotene
My Prescription
Payment
Select pharmacy
$758.40
$30.00 due at pharmacy
$758.40 - $30.00 = $728.40
$728.40 remaining balance
You will be given your coupon after you complete your purchase with PayPal.
WalgreensPowered by$758.40
Print or send this coupon to your phone
WalgreensPowered byAbout Targretin
Drug Details
Bexarotene, marketed as Targretin, is a topical gel specifically used to address skin issues associated with a rare cancer called cutaneous T-cell lymphoma (CTCL). This medication is generally recommended for patients whose condition persists or recurs despite trying other treatments. Bexarotene is classified as a retinoid, a derivative of vitamin A, which functions by inhibiting the growth and proliferation of cancer cells. Although the precise mechanism by which it treats CTCL is not fully understood, its ability to slow or stop cancer cell progression is well-documented. Always consult with your healthcare provider before starting any new treatment to ensure it is safe and appropriate for your situation.
Price history for Targretin (brand) & Bexarotene (generic)
120 Capsules, 75MG
Average retail price for Targretin
Average retail price for Bexarotene
Average SaveHealth price for Bexarotene
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
Over the last 12 months, the average discount price of Targretin is $5041.26 using the SaveHealth savings card. That's an average savings of 86.15% on Targretin with our discount card.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Targretin (Bexarotene) dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 75MG | 120 Capsules | $758.40 | $6.32 |
| 75MG | 100 Capsules | $635.00 | $6.35 |
Targretin FAQs
Targretin is used for the treatment of cutaneous T-cell lymphoma (CTCL) in patients who have not responded well to other systemic therapies.
Bexarotene is not classified as traditional chemotherapy. It is a retinoid, which is a type of medication related to vitamin A, and is used primarily to treat cutaneous T-cell lymphoma.
When taking bexarotene, it is advisable to avoid grapefruit and grapefruit juice. Grapefruit can interfere with the metabolism of the medication, potentially leading to increased levels in the blood and a higher risk of side effects. It is also important to follow any specific dietary recommendations provided by a healthcare provider.
Targretin (bexarotene) is considered effective for the treatment of cutaneous T-cell lymphoma (CTCL) in patients who are refractory to at least one prior systemic therapy. Its effectiveness can vary among individuals, and it is typically evaluated based on the reduction of skin lesions and improvement in symptoms. Clinical trials have shown that a significant number of patients experience a partial or complete response to the treatment. However, the effectiveness can depend on various factors, including the stage of the disease and the patient's overall health. It is important for patients to discuss their specific case with their healthcare provider to understand how Targretin may work for them.
Targretin (bexarotene) works by selectively binding to and activating retinoid X receptors (RXRs). These receptors are involved in regulating gene expression that controls cell growth, differentiation, and apoptosis. By activating RXRs, Targretin can inhibit the growth of certain cancer cells, particularly in cutaneous T-cell lymphoma (CTCL).